Home › NDC Lookup › RxCUI directory › RxCUI 861599

Pentamidine isethionate 50 MG/ML Inhalation Solution [NebuPent] — RxCUI 861599

RxNorm drug concept · Semantic branded drug
RxCUI 861599 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI861599
Official namePentamidine isethionate 50 MG/ML Inhalation Solution [NebuPent]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asNebuPent 50 MG/ML Inhalation Solution; NebuPent 300 MG Inhalation Solution
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)62 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pentamidine Oral Inhalation: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • NebuPent is specifically for prevention, not treatment. It's prescribed to HIV-infected patients who are at high risk of developing a serious lung infection called Pneumocystis jir...
  • What exactly is NebuPent used for — is it a treatment or a prevention?
  • It's a bit different from a standard pocket inhaler. NebuPent is used with a special device called a Respirgard II nebulizer, which turns the medication into a fine mist that you s...
  • How do I use the inhaler — do I just breathe it in like a regular inhaler?
📖 Read our full Pentamidine Oral Inhalation guide →

🕸️ Concept Web — How Pentamidine isethionate 50 MG/ML Inhalation Solu... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Pentamidine isethionate 50 MG/ML Inhalation Solution [NebuPent] RxCUI 861599

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Pentamidine 7994
    • Pentamidine isethionate 7995
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • NebuPent 218646
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pentamidine Inhalation Solution 2108335
    • Pentamidine isethionate Inhalation Solution 2646419
    • Pentamidine Inhalant Product 1164780
    • Pentamidine isethionate Inhalant Product 2659712
    • Pentamidine Inhalation Solution [NebuPent] 2108337
    • Pentamidine isethionate Inhalation Solution [NebuPent] 2658406
    • NebuPent Inhalant Product 1180506
    • Inhalation Solution 346161
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pentamidine isethionate 50 MG/ML Inhalation Solution SCD · 861597
  • Pentamidine isethionate 50 MG/ML SCDC · 861596
  • Pentamidine Inhalation Solution SCDF · 2108335
  • Pentamidine isethionate Inhalation Solution SCDFP · 2646419
  • Pentamidine Inhalant Product SCDG · 1164780
  • Pentamidine isethionate Inhalant Product SCDGP · 2659712

Brand-Name Concepts

  • Pentamidine isethionate 50 MG/ML [NebuPent] SBDC · 861598
  • Pentamidine Inhalation Solution [NebuPent] SBDF · 2108337
  • Pentamidine isethionate Inhalation Solution [NebuPent] SBDFP · 2658406
  • NebuPent Inhalant Product SBDG · 1180506
  • NebuPent BN · 218646

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 861599 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
63323-0877-15 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-877-15) / 6 mL in 1... NebuPent Fresenius Kabi USA, LLC 2011-02-15
Observed labelers: Fresenius Kabi USA, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J2545 Pentamidine non-comp unit 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.